Figure 2.

Some of the barriers and possible solutions for delivering self-collection and HPV testing for cervical cancer screening along the care continuum in the U.S. ^† Need to be paid members of the medical home, which will require a billable CMS code for their services. ^‡ Women who test HPV positive (HPV+) but are negative for HPV16 and HPV18 will need an extra visit for cytology in the U.S. Self-collected specimens cannot be used for cytology because there are not enough diagnostic cells, and it is unlikely that the medium used for the self-collected specimen will preserve whole cells.